Oral fluvoxamine plus budesonide found to cut severe disease in COVID-19

For high-risk outpatients with COVID-19, treatment with oral fluvoxamine plus budesonide reduces the incidence of severe disease needing advanced care, according to a study published online April 18 in the Annals of Internal Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *